Change of the indices of the cytokine status in patients with chronic combined hepatitis B+C in a process of antiviral therapy
The author studied the cytokine status in patients with chronic combined hepatitis B+C in a process of antiviral therapy. The examination embraced 49 patients aged from 18 to 47 years (pegylated interferon- alfa2а and ribavirin were used in 24 patients). It is established, that a significant increas...
Main Author: | O. L. Sobolevskaya |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Journal Infectology
2014-09-01
|
Series: | Журнал инфектологии |
Subjects: | |
Online Access: | https://journal.niidi.ru/jofin/article/view/25 |
Similar Items
-
The efficacy of antiviral treatment in chronic hepatitis B patients with hepatic steatosis
by: Danqing Hu, et al.
Published: (2024-04-01) -
Antiviral activity of lactoferrin: a focus on hepatitis C chronic
by: Emille Tejo Viana, et al.
Published: (2024-04-01) -
Nucleos(t)ide analog therapy of chronic hepatitis B and extrahepatic cancer risk: Is tenofovir better than entecavir?: Editorial on “Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study”
by: Yewan Park, et al.
Published: (2024-10-01) -
Adverse Effects of Combined Antiviral Therapy of Chronic Hepatitis C Virus and Methods for It’s Correction
by: Y. M. Ambalov, et al.
Published: (2011-09-01) -
Predictive Value of Antiviral Effects in the Development of Hepatocellular Carcinoma in the General Korean Population with Chronic Hepatitis B
by: Jae-Jun Shim, et al.
Published: (2016-11-01)